Vertex Pharmaceuticals · Total Current Liabilities

Latest reported$3.86Bperiod endingDec 31, 2025

VRTX FY Current Liabilities ($1.60M → $3.86B)

Annual total current liabilities

High-resolution chart · PNG

VRTX total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	3,861,200,000
Dec 31, 2024	3,564,600,000
Dec 31, 2023	3,547,400,000
Dec 31, 2022	2,742,100,000
Dec 31, 2021	2,142,000,000
Dec 31, 2020	1,877,500,000
Dec 31, 2019	1,334,827,000
Dec 31, 2018	1,120,292,000
Dec 31, 2017	807,260,000
Dec 31, 2016	792,537,000
Dec 31, 2015	506,167,000
Dec 31, 2014	368,254,000
Dec 31, 2013	397,829,000
Dec 31, 2012	432,624,000
Dec 31, 2011	392,348,000
Dec 31, 2010	474,783,000
Dec 31, 2009	284,883,000
Dec 31, 2008	216,564,000
Dec 31, 2007	199,279,000
Dec 31, 2006	251,014,000
Dec 31, 2005	100,243,000
Dec 31, 2004	153,745,000
Dec 31, 2003	139,067,000
Dec 31, 2002	64,597,000
Dec 31, 2001	91,553,000
Dec 31, 2000	69,856,000
Dec 31, 1999	18,518,000
Dec 31, 1998	13,100,000
Dec 31, 1997	13,700,000
Dec 31, 1996	7,100,000
Dec 31, 1995	8,800,000
Dec 31, 1994	6,000,000
Dec 31, 1993	7,300,000
Dec 31, 1992	3,900,000
Dec 31, 1991	2,700,000
Dec 31, 1990	1,600,000